159 related articles for article (PubMed ID: 26845881)
21. Chemotherapy for Malignant Intraocular Tumors.
Shah CP; Shields CL; Shields JA
Dev Ophthalmol; 2016; 55():337-43. PubMed ID: 26501748
[TBL] [Abstract][Full Text] [Related]
22. What's New in Intra-Arterial Chemotherapy for Retinoblastoma?
Abramson DH; Francis JH; Gobin YP
Int Ophthalmol Clin; 2019; 59(2):87-94. PubMed ID: 30908282
[No Abstract] [Full Text] [Related]
23. Electroretinographic changes in the inner retinal layers of the retained eyes of patients with sporadic unilateral retinoblastoma.
Lubiński W; Zajaczek S; Sych Z; Penkala K; Palacz O; Lubiński J
Ophthalmic Genet; 2002 Jun; 23(2):99-107. PubMed ID: 12187428
[TBL] [Abstract][Full Text] [Related]
24. Visual prognosis of retinoblastoma in the posterior pole treated with primary chemotherapy plus local treatments.
Kim JM; Kim JH; Kim SJ; Park KD; Shin HY; Ahn HS; Yu YS
Korean J Ophthalmol; 2010 Dec; 24(6):347-52. PubMed ID: 21165233
[TBL] [Abstract][Full Text] [Related]
25. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.
Gobin YP; Dunkel IJ; Marr BP; Brodie SE; Abramson DH
Arch Ophthalmol; 2011 Jun; 129(6):732-7. PubMed ID: 21320950
[TBL] [Abstract][Full Text] [Related]
26. Combined, sequential intravenous and intra-arterial chemotherapy (bridge chemotherapy) for young infants with retinoblastoma.
Gobin YP; Dunkel IJ; Marr BP; Francis JH; Brodie SE; Abramson DH
PLoS One; 2012; 7(9):e44322. PubMed ID: 23028521
[TBL] [Abstract][Full Text] [Related]
27. Restoration of foveal anatomy and function following chemoreduction for bilateral advanced retinoblastoma with total retinal detachment.
Shields CL; Materin MA; Shields JA
Arch Ophthalmol; 2005 Nov; 123(11):1610-2. PubMed ID: 16286630
[No Abstract] [Full Text] [Related]
28. Pharmacokinetics, Safety, and Efficacy of Intravitreal Digoxin in Preclinical Models for Retinoblastoma.
Winter U; Buitrago E; Mena HA; Del Sole MJ; Laurent V; Negrotto S; Francis J; Arana E; Sgroi M; Croxatto JO; Djaballah H; Chantada GL; Abramson D; Schaiquevich P
Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4382-93. PubMed ID: 26176875
[TBL] [Abstract][Full Text] [Related]
29. Adverse Events, Treatment Burden, and Outcomes of Intravenous versus Intra-arterial Chemotherapy for Retinoblastoma.
Santapuram PR; Schremp EA; Friedman DL; Koyama T; Froehler MT; Daniels AB
Ophthalmol Retina; 2021 Mar; 5(3):309-312. PubMed ID: 32920208
[No Abstract] [Full Text] [Related]
30. Superselective intraophthalmic artery chemotherapy: what we do not know.
Wilson MW; Haik BG; Dyer MA
Arch Ophthalmol; 2011 Nov; 129(11):1490-1. PubMed ID: 22084220
[No Abstract] [Full Text] [Related]
31. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
[TBL] [Abstract][Full Text] [Related]
32. A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
Bartuma K; Pal N; Kosek S; Holm S; All-Ericsson C
Acta Ophthalmol; 2014 Aug; 92(5):404-11. PubMed ID: 24119165
[TBL] [Abstract][Full Text] [Related]
33. Full-field electroretinography under general anesthesia in retinoblastoma.
Sachidanandam R; Krishnakumar S; Gopal L; O'Brien JM; Khetan V; Sen P
Doc Ophthalmol; 2013 Apr; 126(2):149-57. PubMed ID: 23288585
[TBL] [Abstract][Full Text] [Related]
34. Association of electroretinography with visual outcomes after ophthalmic artery chemosurgery for retinoblastoma in ICRb D and E eyes.
Levin AM; Francis JH; McFadden M; Brodie S; Gobin YP; Abramson DH
PLoS One; 2019; 14(1):e0210647. PubMed ID: 30650131
[TBL] [Abstract][Full Text] [Related]
35. Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma.
Munier FL; Beck-Popovic M; Balmer A; Gaillard MC; Bovey E; Binaghi S
Retina; 2011 Mar; 31(3):566-73. PubMed ID: 21273941
[TBL] [Abstract][Full Text] [Related]
36. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy.
Shields CL; Shields JA
Curr Opin Ophthalmol; 2010 May; 21(3):203-12. PubMed ID: 20224400
[TBL] [Abstract][Full Text] [Related]
37. Alternative Chemotherapeutic Agents for the Treatment of Retinoblastoma Using the Intra-Arterial and Intravitreal Routes: A Path Forward Toward Drug Discovery.
Yuan S; Friedman DL; Daniels AB
Int Ophthalmol Clin; 2017; 57(1):129-141. PubMed ID: 27898619
[No Abstract] [Full Text] [Related]
38. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.
Shields CL; Bianciotto CG; Jabbour P; Ramasubramanian A; Lally SE; Griffin GC; Rosenwasser R; Shields JA
Arch Ophthalmol; 2011 Nov; 129(11):1399-406. PubMed ID: 21670328
[TBL] [Abstract][Full Text] [Related]
39. Long-term visual outcome following chemoreduction for retinoblastoma.
Demirci H; Shields CL; Meadows AT; Shields JA
Arch Ophthalmol; 2005 Nov; 123(11):1525-30. PubMed ID: 16286614
[TBL] [Abstract][Full Text] [Related]
40. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis.
Suzuki S; Yamane T; Mohri M; Kaneko A
Ophthalmology; 2011 Oct; 118(10):2081-7. PubMed ID: 21715012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
